HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > Morgan & Morgan

Print e mail rss del Y! myWeb Tweet
 

Actos Lawsuit Attorneys Continue to Investigate Bladder Cancer Claims

The Actos lawsuit attorneys at Morgan and Morgan continue to investigate claims on behalf of patients who were diagnosed with bladder cancer after taking diabetes drug Actos.

(EMAILWIRE.COM, January 27, 2012 ) Orlando, Florida – As the number of Actos lawsuits begins to climb, the attorneys at Morgan and Morgan continue to investigate claims on behalf of users of the diabetes drug who were diagnosed with bladder cancer. Pending Actos bladder cancer lawsuits are alleging that the drug causes bladder cancer and that drug companies Takeda Pharmaceutical Co. and co-defendant Eli Lilly & Co. withheld information and failed to adequately warn doctors and patients about this risk. If you were diagnosed with bladder cancer after taking Actos, you may be able to file an Actos lawsuit to seek compensation for medical bills, pain and suffering and other damages. There is a time limit, however, for filing all Actos bladder cancer claims and failure to take legal action within this window will prevent the patient from ever seeking compensation for their diagnosis. To find out if you have legal recourse, the Actos lawsuit attorneys invite you to visit their website at http://www.forthepeople.com/actos-bladder-cancer-lawsuits--11-3360.html for a free case review.

In June 2011, the FDA announced that the use of diabetes medication Actos for more than a year may be linked to an increased risk of bladder cancer. The agency released the Actos bladder cancer announcement after it reviewed data from an on-going, long-term study of the drug. While the information did not reveal an overall increased Actos bladder cancer risk, it did note an increased risk of bladder cancer among those with the longest exposure to the drug and those exposed to the highest cumulative doses. As a result of the Actos bladder cancer risk, the agency recommended that the drug not be used in those with active bladder cancer and prescribed with caution in patients with a prior history of the disease.

In light of the Actos bladder cancer link, the Actos lawsuit attorneys at Morgan and Morgan continue to offer a free online consultation to patients nationwide. If you or a loved one has been diagnosed with bladder cancer after taking this drug, visit ForThePeople.com today. The Actos lawsuit attorneys at the firm are providing this free case review at no cost and with no obligation.

About Morgan & Morgan

Morgan & Morgan is one of the largest plaintiff’s law firms in the country with multiple office locations throughout Florida and the Southeast. The firm handles auto accident cases, personal injury cases, and medical malpractice cases, as well as claims against drug and medical device manufacturers. Visit Morgan and Morgan online at http://www.forthepeople.com/ for a free case evaluation and information about your legal rights.

Contact Information:
Morgan & Morgan
Michael Goetz
Tel: 877-667-4265
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012